celecoxib and kainic acid

celecoxib has been researched along with kainic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciceri, P; Isakson, PC; Leahy, KM; Seibert, K; Shaffer, AF; Smith, WG; Woerner, MB; Zhang, Y1
Gobbo, OL; O'Mara, SM2
Bosetti, F; Tomita, YA; Toscano, CD; Ueda, Y; Vicini, S1
Caballero-Chacón, S; Feria-Romero, IA; Morales-Sosa, M; Orozco-Suárez, S; Vega-García, A1

Other Studies

5 other study(ies) available for celecoxib and kainic acid

ArticleYear
Pharmacology of celecoxib in rat brain after kainate administration.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Brain; Brain Chemistry; Celecoxib; Cyclooxygenase Inhibitors; Dexamethasone; DNA Primers; Excitatory Amino Acid Agonists; Kainic Acid; Male; Prostaglandins; Pyrazoles; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Seizures; Spinal Cord; Sulfonamides

2002
Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration.
    Neuroscience, 2004, Volume: 125, Issue:2

    Topics: Analysis of Variance; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Celecoxib; Cell Survival; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Escape Reaction; Exploratory Behavior; Hippocampus; Kainic Acid; Male; Maze Learning; Motor Activity; Neurodegenerative Diseases; Neurons; Psychomotor Performance; Pyrazoles; Rats; Rats, Wistar; Reaction Time; Recovery of Function; Seizures; Sulfonamides; Time Factors

2004
Combining exercise and cyclooxygenase-2 inhibition does not ameliorate learning deficits after brain insult, despite an increase in BDNF levels.
    Brain research, 2005, Jun-07, Volume: 1046, Issue:1-2

    Topics: Analysis of Variance; Animals; Brain Damage, Chronic; Brain-Derived Neurotrophic Factor; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Exploratory Behavior; Kainic Acid; Male; Maze Learning; Nerve Degeneration; Physical Conditioning, Animal; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Sulfonamides

2005
Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient mice.
    Brain research bulletin, 2008, Mar-28, Volume: 75, Issue:5

    Topics: Analysis of Variance; Animals; Autoradiography; Celecoxib; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Enzyme-Linked Immunosorbent Assay; gamma-Aminobutyric Acid; Hippocampus; Kainic Acid; Male; Membrane Potentials; Membrane Proteins; Mice; Mice, Knockout; Neurons; Patch-Clamp Techniques; Piperidines; Pyrazoles; Seizures; Statistics, Nonparametric; Sulfonamides; Synaptic Transmission

2008
Immunomodulatory effect of Celecoxib on HMGB1/TLR4 pathway in a recurrent seizures model in immature rats.
    Pharmacology, biochemistry, and behavior, 2018, Volume: 170

    Topics: Animals; Celecoxib; Cyclooxygenase 2; Female; Hippocampus; HMGB1 Protein; Immunologic Factors; Kainic Acid; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Reaction Time; Recurrence; Seizures; Signal Transduction; Toll-Like Receptor 4

2018